6-Methoxypyrido[3,4-d]pyrimidin-4(3H)-one, 98.41%, 50mg

N-(tert-Butoxycarbonyl)-L-isoleucine Hemihydrate>99.0%(T)25g

2-Methoxy-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

8-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one, 97.0%, 1g

2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-6-methylphenol, 96.0%, 10mg

Fmoc-(S)-3-Amino-4-(3-fluorophenyl)-butyric acid, 97%, 1g

(1H-Benzo[d]imidazol-2-yl)methanamine dihydrochloride, 95.0%, 1g

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Syringe filters ROTILABO® Nylon, 0,45 µm, 30 mm, Non-sterile, 100 Piece(s)

4-Nonylpyridine, 95.0%, 1g

ETHYL 5-AMINO-1-(3,3,3-TRIFLUOROPROPYL)-1H-PYRAZOLE-4-CARBOXYLATE, 95.0%, 1g

(2Z)-but-2-enedioic acid; 3-ethyl 5-methyl 2-[(2-aminoethoxy)methylidene]-4-(2-chlorophenyl)-6-methyl-1,2,3,4-tetrahydropyridine-3,5-dicarboxylate, 95%, 1g

MEGA-8, 5 g